Literature DB >> 21730348

Characterization of the gastric immune response in cheetahs (Acinonyx jubatus) with Helicobacter-associated gastritis.

K A Terio1, L Munson, P F Moore.   

Abstract

Captive cheetahs have an unusually severe progressive gastritis that is not present in wild cheetahs infected with the same strains of Helicobacter. This gastritis, when severe, has florid lymphocyte and plasma cell infiltrates in the epithelium and lamina propria with gland destruction, parietal cell loss, and, in some cases, lymphoid follicles. The local gastric immune response was characterized by immunohistochemistry in 21 cheetahs with varying degrees of gastritis. The character of the response was similar among types of gastritis except that cheetahs with severe gastritis had increased numbers (up to 70%) of lamina proprial CD79a+CD21- B cells. CD3+CD4+ T cells were present in the lamina propria, and CD3+CD8α+ T cells were within the glandular epithelium. Lymphoid aggregates had follicular differentiation with a central core of CD79a+/CD45R+ B cells and with an outer zone of CD3+ T cells that expressed both CD4 and CD8 antigens. MHC II antigens were diffusely expressed throughout the glandular and superficial epithelium. No cheetah had evidence of autoantibodies against the gastric mucosa when gastric samples from 30 cheetahs with different degrees of gastritis were incubated with autologous and heterologous serum. These findings indicate that T-cell distribution in cheetahs is qualitatively similar to that in other species infected with Helicobacter but that large numbers of lamina propria activated B cells and plasma cells did distinguish cheetahs with severe gastritis. Further research is needed to determine whether alterations in the Th1:Th2 balance are the cause of this more plasmacytic response in some cheetahs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730348     DOI: 10.1177/0300985811412620

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  8 in total

1.  Integrating evolution in the management of captive zoo populations.

Authors:  Albrecht I Schulte-Hostedde; Gabriela F Mastromonaco
Journal:  Evol Appl       Date:  2015-04-17       Impact factor: 5.183

2.  Pathology in Captive Wild Felids at German Zoological Gardens.

Authors:  Johannes Junginger; Florian Hansmann; Vanessa Herder; Annika Lehmbecker; Martin Peters; Martin Beyerbach; Peter Wohlsein; Wolfgang Baumgärtner
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

3.  Comparative Serum Fatty Acid Profiles of Captive and Free-Ranging Cheetahs (Acinonyx jubatus) in Namibia.

Authors:  Adrian S W Tordiffe; Bettina Wachter; Sonja K Heinrich; Fred Reyers; Lodewyk J Mienie
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

4.  A new perspective on the pathogenesis of chronic renal disease in captive cheetahs (Acinonyx jubatus).

Authors:  Emily P Mitchell; Leon Prozesky; John Lawrence
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

Review 5.  Possibilities and limits for using the gut microbiome to improve captive animal health.

Authors:  Jessica Diaz; Aspen T Reese
Journal:  Anim Microbiome       Date:  2021-12-29

6.  An Investigation of Ovarian and Adrenal Hormone Activity in Post-Ovulatory Cheetahs (Acinonyx jubatus).

Authors:  Diana C Koester; Morgan A Maly; Sarah Putman; Katie L Edwards; Karen Meeks; Adrienne E Crosier
Journal:  Animals (Basel)       Date:  2022-03-22       Impact factor: 2.752

Review 7.  Chronic Stress-Related Gastroenteric Pathology in Cheetah: Relation between Intrinsic and Extrinsic Factors.

Authors:  Sara Mangiaterra; Laurie Marker; Matteo Cerquetella; Livio Galosi; Andrea Marchegiani; Alessandra Gavazza; Giacomo Rossi
Journal:  Biology (Basel)       Date:  2022-04-15

Review 8.  The evolution of powerful yet perilous immune systems.

Authors:  Andrea L Graham; Edward C Schrom; C Jessica E Metcalf
Journal:  Trends Immunol       Date:  2021-12-20       Impact factor: 16.687

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.